Project Details
| Status | Active |
|---|---|
| Effective start/end date | 7/04/26 → 6/04/31 |
Clinical Trial Phase
- Phase II
- External Sponsor
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Safety and Efficacy of AGA2115 in Adults with Type I, III, or IV Osteogenesis Imperfecta (OI)
- Tan, Chin Yao (Primary Chief Investigator (PCI))
Project: Research